Partnerships

The Patient Education Alliance is the Foundation for Women’s Cancer’s new, comprehensive educational sponsorship opportunity. This annually-renewed program offers opportunity to support the core educational needs of our patient community and expanded impact, visibility and collaboration for our partners throughout the year.

We are grateful to our inaugural partners for their unwavering commitment to education and outreach.

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company.
Eisai Co., Ltd. is a Japanese pharmaceutical company.
Genmab A/S is a Danish biotechnology company.
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company.
At Merck, we're following the science to tackle some of the world's greatest health threats.
Seagen is a global biotechnology company dedicated to revolutionizing cancer care.

For more information about this program, please contact Teri Jordan, Chief Industry Relations and Development Officer.

Partnerships

The Patient Education Alliance is the Foundation for Women’s Cancer’s new, comprehensive educational sponsorship opportunity. This annually-renewed program offers opportunity to support the core educational needs of our patient community and expanded impact, visibility and collaboration for our partners throughout the year.

We are grateful to our inaugural partners for their unwavering commitment to education and outreach.

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company.
Eisai Co., Ltd. is a Japanese pharmaceutical company.
Genmab A/S is a Danish biotechnology company.
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company.
At Merck, we're following the science to tackle some of the world's greatest health threats.
Seagen is a global biotechnology company dedicated to revolutionizing cancer care.

For more information about this program, please contact Teri Jordan, Chief Industry Relations and Development Officer.

Partnerships

The Patient Education Alliance is the Foundation for Women’s Cancer’s new, comprehensive educational sponsorship opportunity. This annually-renewed program offers opportunity to support the core educational needs of our patient community and expanded impact, visibility and collaboration for our partners throughout the year.

We are grateful to our inaugural partners for their unwavering commitment to education and outreach.

For more information about this program, please contact Teri Jordan, Chief Industry Relations and Development Officer.